http://dbpedia.org/ontology/abstract
|
5-(2-Aminopropyl)-2,3-dihydrobenzofuran (5 … 5-(2-Aminopropyl)-2,3-dihydrobenzofuran (5-APDB, 3-Desoxy-MDA, EMA-4) is a putative entactogen drug of the phenethylamine and amphetamine classes. It is an analogue of MDA where the heterocyclic 3-position oxygen from the 3,4-methylenedioxy ring has been replaced by a methylene bridge. 6-APDB is an analogue of 5-APDB where the 4-position oxygen has been replaced by a methylene bridge instead. 5-APDB was developed by a team led by David E. Nichols at Purdue University as part of their research into non-neurotoxic analogues of MDMA. In animal studies, 5-APDB's effects generalize most closely to non-stimulant MDMA analogues such as MBDB and MMAI, while producing no substitution for LSD or amphetamine. In vitro studies show that 5-APDB acts as a highly selective serotonin releasing agent (SSRA), with IC50 values of 130 nM, 7,089 nM, and 3,238 nM for inhibiting the reuptake of serotonin, dopamine, and norepinephrine, respectively. In contrast, 6-APDB is more balanced on the three monoamine neurotransmitters and acts more similarly to MDA and MDMA. Methoxy-substituted analogues of 5-APDB and 6-APDB have also been made and substituted for DOM in animal tests, although they were around one tenth as potent as DOM.ey were around one tenth as potent as DOM.
|
http://dbpedia.org/ontology/casNumber
|
152624-03-8
|
http://dbpedia.org/ontology/fdaUniiCode
|
UI10BAJ8SH
|
http://dbpedia.org/ontology/pubchem
|
192601
|
http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/3-desoxy-MDA.svg?width=300 +
|
http://dbpedia.org/ontology/wikiPageID
|
20119063
|
http://dbpedia.org/ontology/wikiPageLength
|
5826
|
http://dbpedia.org/ontology/wikiPageRevisionID
|
1120662770
|
http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Monoamine_neurotransmitter +
, http://dbpedia.org/resource/Substituted_amphetamine +
, http://dbpedia.org/resource/Category:Entactogens_and_empathogens +
, http://dbpedia.org/resource/3%2C4-Methylenedioxyamphetamine +
, http://dbpedia.org/resource/MDMA +
, http://dbpedia.org/resource/In_vitro +
, http://dbpedia.org/resource/MBDB +
, http://dbpedia.org/resource/Functional_group +
, http://dbpedia.org/resource/Entactogen +
, http://dbpedia.org/resource/Category:Designer_drugs +
, http://dbpedia.org/resource/Substituted_phenethylamine +
, http://dbpedia.org/resource/Category:5-Benzofuranethanamines +
, http://dbpedia.org/resource/LSD +
, http://dbpedia.org/resource/Stimulant +
, http://dbpedia.org/resource/Purdue_University +
, http://dbpedia.org/resource/IC50 +
, http://dbpedia.org/resource/Drug +
, http://dbpedia.org/resource/Heterocyclic +
, http://dbpedia.org/resource/Reuptake_inhibitor +
, http://dbpedia.org/resource/Methylene_bridge +
, http://dbpedia.org/resource/Temporary_class_drug +
, http://dbpedia.org/resource/Category:Serotonin_releasing_agents +
, http://dbpedia.org/resource/5-Methyl-6-methoxy-2-aminoindane +
, http://dbpedia.org/resource/Neurotoxic +
, http://dbpedia.org/resource/Dopamine +
, http://dbpedia.org/resource/2%2C5-Dimethoxy-4-methylamphetamine +
, http://dbpedia.org/resource/Serotonin_releasing_agent +
, http://dbpedia.org/resource/Neurotransmitter +
, http://dbpedia.org/resource/Structural_analog +
, http://dbpedia.org/resource/Binding_selectivity +
, http://dbpedia.org/resource/David_E._Nichols +
, http://dbpedia.org/resource/Amphetamine +
, http://dbpedia.org/resource/Category:Substituted_amphetamines +
, http://dbpedia.org/resource/Reuptake +
, http://dbpedia.org/resource/Norepinephrine +
, http://dbpedia.org/resource/Methylenedioxy +
, http://dbpedia.org/resource/Serotonin +
|
http://dbpedia.org/property/atcPrefix
|
none
|
http://dbpedia.org/property/c
|
11
|
http://dbpedia.org/property/casNumber
|
152624
|
http://dbpedia.org/property/chemspiderid
|
167143
|
http://dbpedia.org/property/h
|
15
|
http://dbpedia.org/property/iupacName
|
1
|
http://dbpedia.org/property/legalCa
|
Schedule I
|
http://dbpedia.org/property/legalDe
|
NpSG
|
http://dbpedia.org/property/legalUk
|
Class B
|
http://dbpedia.org/property/n
|
1
|
http://dbpedia.org/property/o
|
1
|
http://dbpedia.org/property/pubchem
|
192601
|
http://dbpedia.org/property/routesOfAdministration
|
Oral
|
http://dbpedia.org/property/smiles
|
Cl.CCCc1cc2CCOc2cc1
|
http://dbpedia.org/property/stdinchi
|
1
|
http://dbpedia.org/property/stdinchikey
|
BZKLFXQUBIRXAK-UHFFFAOYSA-N
|
http://dbpedia.org/property/unii
|
UI10BAJ8SH
|
http://dbpedia.org/property/verifiedfields
|
changed
|
http://dbpedia.org/property/verifiedrevid
|
477223997
|
http://dbpedia.org/property/watchedfields
|
changed
|
http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Phenethylamines +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Chemspidercite +
, http://dbpedia.org/resource/Template:Stdinchicite +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Monoamine_releasing_agents +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Entactogens +
|
http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Serotonin_releasing_agents +
, http://dbpedia.org/resource/Category:Substituted_amphetamines +
, http://dbpedia.org/resource/Category:Designer_drugs +
, http://dbpedia.org/resource/Category:5-Benzofuranethanamines +
, http://dbpedia.org/resource/Category:Entactogens_and_empathogens +
|
http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Drug +
|
http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/5-APDB?oldid=1120662770&ns=0 +
|
http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/3-desoxy-MDA.svg +
|
http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/5-APDB +
|
owl:sameAs |
http://sr.dbpedia.org/resource/5-APDB +
, http://sh.dbpedia.org/resource/5-APDB +
, http://rdf.freebase.com/ns/m.04ygjmb +
, http://yago-knowledge.org/resource/5-APDB +
, https://global.dbpedia.org/id/4JYi6 +
, http://dbpedia.org/resource/5-APDB +
, http://www.wikidata.org/entity/Q4639568 +
|
rdf:type |
http://dbpedia.org/class/yago/Part113809207 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/class/yago/Relation100031921 +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/class/yago/Compound114818238 +
, http://dbpedia.org/class/yago/Chemical114806838 +
, http://dbpedia.org/class/yago/Substance100019613 +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/Material114580897 +
, http://umbel.org/umbel/rc/DrugProduct +
, http://dbpedia.org/class/yago/WikicatBenzofurans +
, http://dbpedia.org/class/yago/Benzofuran114898101 +
|
rdfs:comment |
5-(2-Aminopropyl)-2,3-dihydrobenzofuran (5 … 5-(2-Aminopropyl)-2,3-dihydrobenzofuran (5-APDB, 3-Desoxy-MDA, EMA-4) is a putative entactogen drug of the phenethylamine and amphetamine classes. It is an analogue of MDA where the heterocyclic 3-position oxygen from the 3,4-methylenedioxy ring has been replaced by a methylene bridge. 6-APDB is an analogue of 5-APDB where the 4-position oxygen has been replaced by a methylene bridge instead. 5-APDB was developed by a team led by David E. Nichols at Purdue University as part of their research into non-neurotoxic analogues of MDMA.rch into non-neurotoxic analogues of MDMA.
|
rdfs:label |
5-APDB
|